• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Latest News

With the Rise of GLP-1 Agonists for Treating Obesity, Will Access Challenges Prevent Progress?
With the Rise of GLP-1 Agonists for Treating Obesity, Will Access Challenges Prevent Progress?

March 1st 2024

JAMA commentary suggests that issues such as high costs, access, and equity will stop patients from obtaining GLP-1 agonists to treat obesity.

Image credit: Timon | stock.adobe.com. Mobile phone with logo of Centers for Medicare and Medicaid Services (CMS) on screen in front of website. Focus on center-left of phone display
CMS Signals Looming Sunshine Act Audits: How to Prepare

March 1st 2024

Bristol Myers Squibb Reveals Promising Results from Trial of Zeposia for Multiple Sclerosis
Bristol Myers Squibb Reveals Promising Results from Trial of Zeposia for Multiple Sclerosis

March 1st 2024

Simon Bruce
The State of Obesity-Related Clinical Research: Q&A with Simon Bruce, Vice President, Internal Medicine, Drug Development Solutions, ICON

March 1st 2024

stock.adobe.com
CDC’s Advisory Committee Recommends Another Round of Covid-19 Shots for Seniors

March 1st 2024

Conference Coverage

View All
Image credit: Design Cells | stock.adobe.com
Novartis' Lutathera Shows Significant Survival Benefit as First-Line Treatment for GEP-NETs

January 19th 2024

Eisai
Eisai To Present New Data For Gastrointestinal Cancer Research at ASCO GI 2024

January 17th 2024

Image credit: Lucky Ai | stock.adobe.com
Presentation at J.P. Morgan Healthcare Conference Highlights Growth of Platform for AI, Data

January 15th 2024

stock.adobe.com
Dexcom Announces Preliminary and Unaudited Revenue For Fourth Quarter and Fiscal Year 2023

January 12th 2024

Latest Videos
Podcasts

All News